Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia

Behav Brain Res. 2001 Sep 28;124(1):9-18. doi: 10.1016/s0166-4328(01)00211-x.

Abstract

Intra-nigral administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) caused a lesion in the substantia nigra, compact part (SNc) and a specific loss of dopamine and its metabolites in the striatum of rats. The animals were then tested in the two-way active avoidance task. MPTP-treated animals presented lower learning scores in the training and test sessions, an effect that was not caused by motor impairment or by a decreased sensitivity to footshock since their reaction time to the footshock (unconditioned stimulus - UCS) was not reduced. These lower scores were also not attributable to lower acoustic sensitivity or to a slowing in the association of the sound cue (conditioned stimulus - CS) with the UCS since the reaction time to the CS in the active avoidance response did not differ between MPTP-treated and control groups. Therefore, these results are more properly attributable to an impairment of the memory acquisition and retention processes. In addition, this study is presented as a model of early Parkinson's Disease amnesia and is discussed in terms of the importance of the nigrostriatal pathway to memory acquisition and storage processes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine* / pharmacology
  • Animals
  • Association Learning / drug effects
  • Association Learning / physiology
  • Avoidance Learning / drug effects*
  • Avoidance Learning / physiology
  • Conditioning, Classical / drug effects
  • Conditioning, Classical / physiology
  • Dopamine / metabolism
  • Male
  • Mental Recall / drug effects*
  • Mental Recall / physiology
  • Neural Pathways / drug effects
  • Neural Pathways / physiopathology
  • Parkinsonian Disorders / chemically induced*
  • Parkinsonian Disorders / physiopathology
  • Rats
  • Rats, Wistar
  • Retention, Psychology / drug effects
  • Retention, Psychology / physiology
  • Substantia Nigra / drug effects*
  • Substantia Nigra / physiopathology

Substances

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Dopamine